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Multidrug resistance protein-mediated transport of
chlorambucil and melphalan conjugated to glutathione
K Barnouin, I Leier, G Jedlitschky, A Pourtier-Manzanedo, J Konig, W-D Lehmann and D Keppler
Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany
Summary The human multidrug resistance protein (MRP1) confers resistance of cells to a number of different cytostatic drugs and functions
as an export pump for glutathione S-conjugates, glucuronides and otheramphiphilic anions. The present study details forthe first time MRP1-
mediated ATP-dependent transport of various glutathione S-conjugates of the bifunctional alkylating agents chlorambucil and melphalan. In
membrane vesicles prepared from cells expressing recombinant MRP1, the conjugates were transported at rates in the following order:
monoglutathionyl chlorambucil > bisglutathionyl chlorambucil > monohydroxy monoglutathionyl chlorambucil and monoglutathionyl melphalan
> monohydroxy monoglutathionyl melphalan. In addition, we show that membranes from chlorambucil-resistant GST-a-overexpressing CHO
cells as well as from their parental cells express the hamster homologue of MRP1. With both CHO cell membrane preparations, we observed
ATP-dependent transport of monoglutathionyl chlorambucil and of leukotriene C4, a glutathione S-conjugate and high-affinity substrate of
MRP1. The transport rates measured in the resistant cells were only two- to three-fold higher than those measured in the control cells. These
results together with cytotoxicity assays comparing MRP1-overexpressing cell pairs with the CHO cell pair indicate that, although MRP1-
mediated transport is active, it may not be the rate-limiting step in chlorambucil resistance in these cell lines.
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The multidrug resistance protein (MRP1) has been shown to
be an ATP-dependent export pump for amphiphilic conjugates,
including several glutathione S-conjugates, such as the high-
affinity endogenous substrate leukotriene C4 (LTC4) (Jedlitschky et
al, 1994; Leier et al, 1994a; Muller et al, 1994), oxidized
glutathione (GSSG) (Leier et al, 1996) and xenobiotic conjugates
such as S-(2,4-dinitrophenyl)glutathione (Leier et al, 1994a;
Jedlitschky et al, 1994; Muller et al, 1994) and monoglutathionyl
melphalan (Jedlitschky et al, 1996). In addition, MRP1 substrates
include a number of sulphated and glucuronidated compounds
(Jedlitschky et al, 1996, Loe et al, 1996a,b).
Melphalan and chlorambucil are bifunctional alkylating agents
commonly used in the treatment of several types of cancers
(Terenbaum, 1994). Acquired resistance, however, often hinders
the success of chemotherapy. It is known that resistance to alkyl-
ating agents is associated with increased glutathione levels and
GST activity (Hayes and Pulford, 1995; O'Brien and Tew, 1996).
The a-isoform ofthe glutathione transferases (GST), the most effi-
cient enzyme catalysing the glutathione conjugation to these drugs,
has been isolated and purified from cell lines selected forresistance
to melphalan or chlorambucil, as well as from human and mouse
liver cytosol and from human kidney cytosol (Lewis et al, 1988;
Ciaccio et al, 1990; Meyer et al, 1993). In addition, the glutathione
S-conjugates of both drugs have been characterized by fast atom
bombardment mass spectrometry (Dulik et al, 1986, 1990).
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In this study, the transport of the different glutathione S-conju-
gates of these alkylating agents into membrane vesicles prepared
from MRPI-transfected and control HeLa cells was determined.
Interestingly, we found that the hamster homologue of MRP1
(termed as Mrpl in rodents) is expressed in membranes from
chlorambucil-resistant CHO cells that overexpress GST-a as well
as in control CHO-KI cells. We therefore examined the transport
ofLTC4 and monoglutathionyl chlorambucil in these membranes.
MATERIALS AND METHODS
Materials
[14,15,19,20-3H4]LTC4 (4.7 TBq mmol-') and [glycine-2-3H]-
glutathione (1.7 TBq mmol-') were purchased from DuPont
New England Nuclear (Boston, MA, USA). [G-3H]Chlorambucil
(180 GBq mmol-1) and [chloroethyl-1,2-14C]melphalan (1.85 GBq
mmol-1) were obtained from Moravek Biochemicals (Brea, CA,
USA). Unlabelled LTC4 and the enhanced chemiluminescence
(ECL) detection kit were from Amersham-Buchler (Braunschweig,
Germany). Unlabelled chlorambucil, melphalan and glutathione
(GSH) were from Sigma Chemical (St Louis, MO, USA). Nick-
spin columns filled with Sephadex G-50 fine were obtained from
Pharmacia-LKB (Freiburg, Germany) and nitrocellulose filters
from Schleicher & Schull (Dassel, Germany).
Cells
The cell lines HeLa (human cervix carcinoma cell line), HL60
(human promyelocytic leukaemia), and GLC4 (human small lung
cell carcinoma) were cultured in RPMI medium supplemented with
10% fetal calf serum (FCS), 100 IU ml-' penicillin/streptomycin
and 10gIM a-thioglycerol. The drug-selected MRPl-overexpressing
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HL60/ADR cells were kept in the presence of200 nm daunorubicin
(Krishnamachary and Center, 1993) and the GLC4/ADR cells in the
presence of 1.2gM doxorubicin (Zijlstra et al, 1987). The MRPJ-
transfected HeLa T5 and the control vector-transfected HeLa Cl
cells (kindly provided by Drs RG Deeley and SPC Cole, Kingston,
Ontario, Canada) were kept under their selection agent geneticin
(600,M) (Cole et al, 1994). The chlorambucil-resistant GST-a
overexpressing CHO-Chlr (Chinese hamster ovary) and control
CHO-Kl cells (kindly providedby DrAHall, Newcastle, UK) were
grown in FIO (Ham) medium containing 10% FCS and 100 IU ml-1
penicillin/streptomycin (Robson et al, 1986).
Synthesis and purification of chlorambucil and
melphalan glutathione S-conjugates
[3H]Chlorambucil or [14C]melphalan were incubated with 10 mm
unlabelled GSH and with CHO-Chlr cytosol (100 ,ug ofprotein per
100gl) at pH 6.5 and at 37°C for 30 and 60 min respectively.
Incubation times were increased to 120 min when more of the
bisglutathionyl or monohydroxy monoglutathionyl S-conjugates
were required. In addition, [3H]GSH was incubated with unla-
belled melphalan after removal of the dithiothreitol from GSH by
ethyl acetate extraction (Akerboom and Sies, 1994); this was done
to avoid the synthesis of mixed disulphides between GSH and
DTT. All incubations were terminated and protein was precipitated
by addition of ice-cold ethanol at a final concentration of 75%
(v/v). This mixture was kept for at least 2 h at -20°C before
centrifugation and high-performance liquid chromatography
(HPLC) separation.
Chlorambucil glutathione S-conjugates were purified using a
two-step RP-HPLC procedure with a C18 Hypersil column. Flow
rates were set at 1 ml min-'. In step one, buffer A consisted of
5 mM ammonium acetate in water pH 5.7 and buffer B of 5 mm
ammonium acetate in 80% methanol pH 5.7. The column was
equilibrated with buffer A. From 5 to 50 min, a linear gradient ran
from 50% A/50% B to 100% B followed by 10 min with buffer B.
In this first step, bisglutathionyl chlorambucil and monohydroxy
monoglutathionyl chlorambucil were eluted in one peak. These
conjugates were then separated with the second HPLC system.
Buffer A was composed of 0.065% trifluoracetic acid (TFA)
in water and buffer B of 0.05% TFA in 80% acetonitrile.
Equilibration of the column with buffer A was followed by a
30-min linear gradient to 75% A/25% B, which then ran with this
solvent mixture isocratically for 10 min.
Monoglutathionyl melphalan and monohydroxy monogluta-
thionyl melphalan were purified by RP-HPLC with a C,8 Hypersil
column with the following solvent system: buffer A was composed
of0.1% acetic acid in water pH 5.7 and buffer B 0.1% acetic acid
in 38% acetonitrile pH 5.7. The column was equilibrated with
buffer A followed by a 35-min lineargradient to 100% B. Buffer B
then ran isocratically for 15 min.
Electrospray ionization mass spectrometry (ESI-MS)
Electrospray mass spectra were recorded on a Finnigan MAT
TSQ 7000 triple quadrupole mass spectrometer (Palo Alto, CA,
USA) equipped with an ESI ion source (Fenn et al, 1988;
Voyksner, 1992). The standard spray needle assembly was
replaced by a nanoelectrospray ion source (The Protein Analysis
Company, Odense, Denmark) (Wilm and Mann, 1996). The
spray needle was positioned on-axis about 1 mm from the heated
capillary orifice held at 150°C. The analysis was performed at an
estimated flow rate of 20-50 nl min-'. Sample solutions in 80%
aqueous methanol (v/v) were sprayed with a needle potential
of ±500-800 V. Tandem mass spectrometry experiments were
performed with argon as collision gas at a pressure of 2 mTorr.
Between 30 and 100 repetitive scans ofproduct ion spectra were
recorded and averaged.
Transport studies with membrane vesicles
Membrane vesicles were prepared as described previously (Leier
et al, 1994b). The ATP-dependent transport of radioactively
labelledchlorambucil, melphalan and theirglutathioneS-conjugates
into inside-out membrane vesicles was measured using the Nick-
spin column filtration method essentially as described (Bohme et
al, 1993; Biichler et al, 1994). In brief, the radioactive substrates
were incubated in the presence of 4 mm ATP or 4 mM AMP-PCP,
an ATP-regenerating system, and 15 jg of membrane protein per
55 gl assay volume in an incubation buffer containing 250 mM
sucrose and 10 mM Tris-HCl, pH 7.4 at 37°C. In addition,
[3H]chlorambucil transport was tested in the presence of 10 mm
GSH in the incubation medium according to measurements
described by Loe et al (1996b). Aliquots were taken and the reac-
tion was stoppedby directdeposit on the Nick-spin column cooled
to 4°C, columns were rinsed with 190 jil incubation buffer and
immediately centrifuged for 3.5 min at 400g. The eluates were
counted forradioactivity.
[3H]LTC4 transport was performed as described above, except
that the vesicles were filtered through nitrocellulose filters
(0.22 jm pore size) presoaked with incubation bufferusing arapid
filtration device (Leier et al, 1994b).
Cytotoxicity tests
Cell proliferation was assayed according to Mosman (1983), with
modifications as described by Pourtier-Manzanedo et al (1991).
Cells that were normally cultivated under drug-selection pressure
were washed and resuspended in fresh medium without the
selecting agent 24 h before starting the experiment. Untreated cells
and cells pretreated 24 h with 50 jM buthionine sulphoximine
(BSO) were deposited in 96-well microtitre plates (3000 cells
per well) and exposed to varying chlorambucil concentrations.
Dimethyl sulphoxide (DMSO) was used to prepare a chlorambucil
stock solution, this was diluted in medium according to thehighest
drug concentration and subsequently serially to the required
concentrations. As a control, the highest DMSO concentration
used in the assay was checked to ensure that it did not affect the
measurements of chlorambucil cytotoxicity. After 3 days of incu-
bation at 37°C/5% carbon dioxide, 100 jl ofmedium per well was
removed and replaced with 20jil ofMTT (3-[4,5-dimethylthiazol-
2-yl]2,5-diphenyl tetrazolium bromide; 2.5 mg ml-'). The plates
were incubated for 2-3 h and the formazan crystals were dissolved
by addition of 100 jil of 2-butanol-isopropanol-IM hydrochloric
acid (16:8:1 v/v/v), shortly sonicated, mixed and the absorption
was read at 570 nm. Cell viability is given by the relative absorp-
tion in per cent ofcells grown without drug.
In contrast to melphalan, uptake of chlorambucil is not
markedly influenced by the amino acids in the culture medium
(Begleiter and Goldenberg, 1983) and was therefore chosen forthe
growth inhibition assay. The uptake of melphalan into intact cells
can be inhibited by amino acids that are present in cell culture
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media at relatively high concentrations (Vistica, 1983). As growth
inhibition assays are performed in the presence of cell culture
media, the presence of these amino acids would influence the
uptake ofmelphalan and prevent a correct analysis ofcytotoxicity.
Immunoblot
Membrane proteins were separated on a 7.5% acrylamide gel.
Immunoblotting was performed essentially according to
Towbin et al (1979) with a tank blotting system and ECL
detection. The polyclonal antibody 6KQ was raised in
rabbits against the carboxyl-terminal sequence of MRP1
(Krishnamachary et al, 1994).
Reverse transcription PCR, cloning and sequence
analysis
Total RNA was isolated from CHO cells using the RNA-Clean
System kit (Angewandte Gentechnologie Systeme, Heidelberg,
Germany). Reverse transcription polymerase chain reaction
(RT-PCR) analysis was performed as described (Mayer etal, 1995;
Buchler et al, 1996). The amplification proceeded through 35
cycles at 94°C for 1 min, 50°C for 1 min and 72°C for 1 min.
Using the sense and anti-sense primers (ForIIIVRevIII), a 182-bp
fragment complementary to aregion in the first nucleotide binding
domain of human MRP1 was amplified (Mayer et al, 1995).
Subsequently, the PCR fragment was subcloned into the pCR-
Script SK(+) plasmid (Stratagene, La Jolla, CA, USA) and inte-
grated into competent E. coli. DNA sequencing was performed
according to Sanger et al (1977).
RESULTS
Identification and isolation of glutathione S-conjugated
chlorambucil and melphalan
HPLC separation and subsequent ESI-MS analysis demonstrated
that chlorambucil and melphalan, in the presence of GSH and
cytosol from GST-a-overexpressing CHO-Chlr cells, form
covalent glutathione S-conjugates. Three different glutathione
S-conjugates ofthese two nitrogen mustards can be produced: the
monoglutathionyl S-conjugate, the monohydroxy glutathionyl
S-conjugate and the bisglutathionyl S-conjugate (Dulik et al,
1986, 1990; Ciaccio et al, 1990). This is exemplified for
chlorambucil in Figure 1. Chlorambucil glutathione S-conjugates
were separated using a two-step HPLC procedure. In step 1,
monoglutathionyl chlorambucil, (M2, Figure lA and C) was
separated from native chlorambucil (MI, Figure lA and B) and
from monohydroxy monoglutathionyl chlorambucil andbisgluta-
thionyl chlorambucil. The last two compounds were eluted in one
peak (Figure IA, M3 + M4) and were separated using a second
HPLC system (Figure ID-F).
Using our HPLC system, only monoglutathionyl and hydroxy
glutathionyl melphalan were isolated. Comparison of HPLC
chromatograms of double-labelled melphalan glutathione
S-conjugate and ESI-MS analysis confirmed the isolation of
these two glutathione conjugates (not shown). On-line liquid
chromatography-ESI-MS studies using a more polar column
revealed that the bisglutathionyl melphalan S-conjugate was
eluted in the aqueous phase ofthe gradient in the present system
(not shown).
Transport of chlorambucil and melphalan glutathione
S-conjugates into HeLa T5 and HeLa Cl membrane
vesicles
ATP-dependent transport of 1 ,UM [3H]chlorambucil glutathione
S-conjugate (Figure 2) and 0.2 gM melphalan [3H]glutathione
S-conjugate was measured in membrane vesicles prepared from
MRPI-overexpressing HeLa T5 and from HeLa Cl control
cells. As shown in Table 1, for both chlorambucil and
melphalan, the monoglutathionyl S-conjugates had higher trans-
port rates than the bisglutathionyl and the monohydroxy monog-
lutathionyl conjugates. The transport rates of the glutathione
S-conjugates in HeLa T5 membrane vesicles were at least five
times higher than those measured in HeLa Cl membrane vesi-
cles (Table 1 and Figure 2). The chlorambucil monohydroxy
monoglutathionyl S-conjugate exhibited a low transport rate in
the same order of magnitude as native chlorambucil, but a clear
difference was observed when transport rates into HeLa T5 and
into HeLa Cl membrane vesicles were compared. Native
[3H]chlorambucil was not a MRP1 substrate as it was trans-
ported into membranes from MRPI-transfected HeLa T5 and
control HeLa C cells at similar low rates (Table 1). Also, in the
presence of GSH in the incubation medium, no transport of this
alkylating agent was detected. Because of the low specific
activity of [14C]melphalan, transport of this native compound
was assayed at higher concentrations. Up to 40 gM, no signifi-
cant ATP-dependent transport was detectable for this compound
in membrane vesicles from both HeLa cell lines (Table 1). For
comparison, transport of40 gM [14C]melphalan as well as 40 gM
monoglutathionyl [14C]melphalan was assayed in membrane
vesicles prepared from the MRP1-overexpressing HL60/ADR
and from the parental cell lines. With these membranes, ATP-
dependent transport was also not detected with 40 gM
['4C]melphalan. In contrast, monoglutathionyl ['4C]melphalan at
this concentration was transported in HL60/ADR membrane
vesicles with a transport rate of 154 pmol mg-1 min-'. These
results indicate that glutathione conjugation ofchlorambucil and
melphalan is necessary for these compounds to be MRP1
substrates.
Mrpl detection in CHO-Kl and CHO-Chir membrane
vesicles
Immunodetection using the polyclonal antibody 6KQ directed
against the carboxyl-terminal sequence ofMRP1 (Krishnamachary
et al, 1994) indicated that a 190-kDa hamster homologue ofMRP1
is expressed in membranes ofboth CHO cell lines (Figure 3). These
results were confirmed by analysing the expression of the hamster
homologue of MRPl by PCR amplification of cDNA reverse
transcribed from CHO-KI and from CHO-Chlr cell mRNA and
subsequent sequencing of the obtained 182-bp fragment. The
amino acid sequence deduced from this fragment was 88% and
80% identical to and 93% and 88% similar to murine Mrpl (Stride
et al, 1996) and human MRP1 (Cole et al, 1992) respectively
(Figure 3). The amino acid sequence excluding the primer regions
(i.e. amino acids 720-760) was 85% and 73% identical to and
93% and 85% similar to murine Mrpl and human MRP1 respec-
tively. This partial sequence was only 65% identical to and 75%
similar to the rat canalicular Mrpl isoform (Biichler et al, 1996)
(not shown).
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Figure 1 Identification by HPLC and ESI-MS of [3H]chlorambucil and its glutathione S-conjugates. A and D represent chromatograms of the first and second
HPLC purification systems respectively. (B and C) ESI-MS spectra of chlorambucil (Ml) and monoglutathionyl chlorambucil (M2) isolated with the HPLC system
1. (E and F) ESI-MS spectra of monohydroxy monoglutathionyl chlorambucil (M3) and bisglutathionyl chlorambucil (M4) isolated with the HPLC system 2
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Figure 2 MRP1-mediated transport of monoglutathionyl chlorambucil and bisglutathionyl chlorambucil into HeLa T5 and HeLa Cl membrane vesicles.
Transport of 1 gM monoglutathionyl [3H]chlorambucil (upper left panel) and 1 gM bisglutathionyl [3H]chlorambucil (lower left panel) in the presence of 4 mM ATP
(A) or its non-hydrolysable analogue AMP-PCP (V) into HeLa T5 membrane vesicles. ATP-dependent transport of these substrates into HeLa T5 (-) and into
HeLa Cl (C]) membranes was determined by subtracting transport rates measured in the presence of AMP-PCP from those measured in the presence of ATP
(right panels). Mean values of at least three assays. Bars represent s.d.
Table 1 Rates of ATP-dependent transport of [3H]chlorambucil and [14C]melphalan and their [3H]glutathione
S-conjugates into HeLa T5 and HeLa Cl membrane vesicles
Concentration Transport (pmol mg-' min-')
(tIM)
Substrate HeLa T5 HeLa Cl
Chlorambucil 1 0.8 ± 0.4 0.9 ± 0.8
Monoglutathionyl chlorambucil 1 6.7 ± 1.4 1.3 ± 0.3
Monohydroxy monoglutathionyl chlorambucil 1 0.3 ± 0.2 <0.01
Bisglutathionyl chlorambucil 1 3.0 ± 1.6 0.4 ± 0.3
Melphalan 40 <0.01 <0.01
Monoglutathionyl melphalan 0.2 2.2 ± 0.3 <0.01
Monohydroxy monoglutathionyl melphalan 0.2 0.6 ± 0.3 0.1 ± 0.04
Assays were performed using the column filtration method as described in Materials and methods. Data
represent mean values from three to eight single transport measurements ± s.d.
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Figure 3 (A) Immunodetection of Mrpl in CHO-Kl and CHO-Chlr membranes using anti-MRP1 polyclonal antibody 6KQ (Krishnamachary et al, 1994).
Membrane proteins from CHO-K1, from CHO-Chlr and from HeLa T5 cells were analysed as described in Materials and methods. The amount of protein was
loaded as indicated. (B) Amino acid sequence deduced from a 182-bp fragment of the hamster MRP1 homologue. Numbers indicate amino acid position of
murine (Stride et al, 1996) as well as human MRP1 (Cole et al, 1992). Amino acids of this partial sequence from hamster Mrp1 were 88% and 80% identical to
murine Mrpl and human MRP1 respectively
Transport of chlorambucil, monoglutathionyl
chlorambucil and LTC4 into CHO-Kl and CHO-Chlr
membrane vesicles
[3H]Chlorambucil, at a concentration of 1 ,UM, was poorly trans-
ported into membrane vesicles of both CHO cell lines. However,
monoglutathionyl [3H]chlorambucil and [3H]LTC4 were trans-
ported into these membrane vesicles. Transport rates in the
chlorambucil-resistant cell line CHO-Chlr were 3.0 and 2.4 times
higher for monoglutathionyl [3H]chlorambucil and [3H]LTC4,
respectively, than those measured with the control CHO-KI
membranes (Figure 4 and Table 2).
Growth inhibition assay of MRP1-expressing cell lines
in the presence of chlorambucil and resistance
modulation by buthionine sulphoximine pretreatment
The resistance ofHL60, GLC4, HeLa and CHO cell lines to chlor-
ambucil was investigated. In the case of the HL60 and HeLa cell
lines, the respective parental and MRP1-overexpressing cell lines
were similarly sensitive to chlorambucil with resistance factors
(RF) close to 1 (Table 3). The GLC4 and GLC4/ADR cell line pair,
however, differed in its IC50 values (Table 3) with a RF for the
GLC4/ADR cells of2.5. This RF was reduced by 28% when these
cells were pretreated for 24 h with 50gM BSO. The CHO cell line
pair showed a marked difference in resistance with the RF for the
CHO-Chlr equal to 5.6 (Table 3). Pretreatment of the CHO cell
lines with BSO reduced the resistance factor of the CHO-Chlr by
40% (Table 3).
DISCUSSION
MRP1, a 190-kDa membrane glycoprotein conferring resistance of
cells to several structurally unrelated cytostatic drugs (Zaman et al,
1995; Loe et al, 1996c), has been shown to be ahigh-affinity export
pump for several glutathione S-conjugates (Jedlitschky et al, 1994,
1996; Leieretal, 1994a, 1996; Muller et al, 1994). We demonstrate
in the present study that the various glutathione S-conjugates of
chlorambucil and melphalan are substrates for human MRP1 using
membrane vesicles prepared from MRPI-transfected cells (Table 1
and Figure 1). However, differences in functional groups or
hydrophobicity modify the transport rates. Monoglutathionyl chlo-
rambucil was a better substrate than monohydroxy glutathionyl
chlorambucil, with a 22-fold higher initial transport rate (Table 1).
Moreover, the initial transport rate ofmonoglutathionyl melphalan
was 3.7-fold higher than that of monohydroxy monoglutathionyl
melphalan (Table 2). Also noteworthy is that the number of
glutathione moieties conjugated to a compound affects the trans-
port rate. Bisglutathionyl chlorambucil, for instance, was a poorer
MRP1 substrate than monoglutathionyl chlorambucil but better
than monohydroxy monoglutathionyl chlorambucil (Table 1).
Native chlorambucil, which is itself an amphiphilic anion, was not
a substrate forMRP1; also, in the presence ofGSH, no transport of
this drug was detected. Under the same condition, we were able to
measure vincristine transport as it was previously described by Loe
et al (1996b). Native melphalan, which is a zwitterion at physiolog-
ical pH, was not found to be a MRP1 substrate (Table 1). This indi-
cates that conjugation of these alkylating agents to glutathione is
necessary for their export from cells.
So far no cross-resistance of MRP1-overexpressing cells to
chlorambucil and melphalan has been described. The finding that
the control CHO-Ki as well as the chlorambucil-resistant CHO-
Chlr cells overexpressing GST-a (Lewis et al, 1988) express the
hamster homologue of MRP1 (Figure 3) provided a means to
investigate the role of MRP1 in cells selected for resistance to
chlorambucil. The detection of Mrpl expression in the CHO-KI
cells confirms an earlier speculation by Turner and Curtin (1996).
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Figure 4 ATP-dependent transport of monoglutathionyl chlorambucil into CHO-ChIl and CHO-Kl membrane vesicles. Transport assays with CHO-Chlr (A) and
CHO-Kl (B) membrane vesicles were performed with 1 gM monoglutathionyl [3H]chlorambucil in the presence of ATP (A, A) or AMP-PCP (V, V). Rates of
ATP-dependent transport (U, O) (C) were determined as described in the legend to Figure 2. Mean values of at least three assays. Bars represent s.d.
Table 2 Rates of ATP-dependent transport of [3H]chlorambucil, monoglutathionyl [3H]chlorambucil and
[3H]LTC4 into CHO-Chlr and CHO-Kl membrane vesicles
Transport (pmol mg-' min-')
Substrate Concentration(gM) CHO-Chlr CHO-KI
Chlorambucil 1 0.2 ± 0.2 <0.1
Monoglutathionyl chlorambucil 1 2.5 ± 0.3 0.8± 0.1
LTC4 0.05 8.0 ± 2 3.3 ± 0.8
Transport assays with [3H]chlorambucil and monoglutathionyl [3H]chlorambucil were performed using the
column filtration method and with LTC4 using the nitrocellulose filtration method as described in Materials
and methods. Data represent mean values from three to eight single transport measurements ± s.d.
Table 3 Cytotoxic effect of chlorambucil on MRP1-expressing cell lines and
modulation of resistance by BSO pretreatment for 24 h
Cell line BSO IC5 Resistance factor
(50gM) (gM)
HL60 - 5.6±0.7(3) 1.0±0
HL60/ADR - 6.9 ± 0.4 (4) 1.3± 0.1
HeLa Cl - 17.7 ±3.5 (4) 1.0 ± 0
HeLa T5 - 14.2 ± 5.4 (6) 0.8 ± 0.3
GLC4 - 2.8±0.3 (3) 1.0
+ 2.4 ± 0.2 (3) 0.9
GLC4/ADR - 6.9 ± 0.5 (3) 2.5
+ 4.9 ± 1.0* (3) 1.8
CHO-Kl - 24.3 ± 2.4 (3) 1.0
+ 28.8±4.2 (2) 1.2
CHO-Chir - 136 ± 5.6 (3) 5.6
+ 79.0 ± 22.4* (2) 3.3
IC50 values were determined with the growth inhibition assay as described in
Materials and methods. IC50 values represent means ± s.d. from number of
experiments (n) with triplicate determinations. The resistance factor was
determined by dividing the IC , value of each cell line by the IC5 value of the
respective untreated parental cell line. Statistical significance for the
modulation by BSO, *P < 0.025 (Student's t-test).
Transport rates of monoglutathionyl chlorambucil and leukotriene
C4 (LTC4) were higher in the CHO-Chlr than in the CHO-KI
membrane vesicles (Table 2 and Figure 4). In concordance with
the transport data, the CHO-Chlr membranes showed a slightly
more intense signal in the immunodetection of the hamster
homologue ofMRP1 than the CHO-Kl membranes (Figure 3). The
resistance of the CHO-Chlr cells to chlorambucil indicates that the
low amount ofhamster Mrpl present in these cells, compared with
the MRPI-overexpressing human cells, is sufficient to mediate the
export ofthe glutathione S-conjugates ofthese alkylating agents.
Among the human MRP1-overexpressing cells tested in the
present study, only the GLC4/ADR cells showed an enhancedchlor-
ambucil resistance compared with their respective parental cell line
(Table 3), despite the fact that the glutathione S-conjugates ofchlo-
rambucil and melphalan were also transported into membrane vesi-
cles of the other MRPl-overexpressing cells used (Table 1 and
Figure 2). The modulation ofresistance ofthe GLC4/ADR cell line
to chlorambucil by pretreatment with BSO (Table 3) underlines that
the conjugation to glutathione is a necessary step in the resistance
mechanism to this agent in this cell line. An increased requirement
for GSH necessitates an increase in its synthesis and recycling.
Consequently, all GSH-related synthetic and conjugating enzymes
are crucial in this type ofresistance (O'Brien and Tew, 1996).
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As a measure of MRP1 activity, transport of the high-affinity
substrate LTC4 can be used (Jedlitschky et al, 1994; Leier et al,
1994a; Muller et al, 1994). LTC4 transport rates have been deter-
mined to be 25-fold higherin HL60/ADR (Jedlitschky et al, 1994),
tenfold higher in HeLaT5 (Leier et al, 1994a) and eightfold higher
in GLC4/ADR (Muller et al, 1994) than those measured in the
membrane vesicles of the respective parental cell lines. In the
present investigation, however, from these cell lines only the
GLC4/ADR cells showed a resistance factor against chlorambucil
ofabout 2.5. The resistance factors ofthe other two cell lines were
close to 1 (Table 3). The resistance factor for CHO-Chlr cells to
chlorambucil was significantly higher (Table 3) but LTC4 transport
activity was only 15-30% of that observed in the MRP1-
overexpressing cells (Table 2; Jedlitschky et al, 1994; Leier et al,
1994a). Thus, increased transport ofglutathione S-conjugates does
not necessarily indicate increased resistance to the bifunctional
alkylating agents.
Our results underline the broad substrate specificity of MRP1.
In addition, for the alkylating agents studied, conjugation to
glutathione, rather than MRP1 activity, appears to be the rate-
limiting step in their detoxification.
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